Nuclear Medicine and Biology
Volume 36, Issue 7 , Pages 759-770, October 2009

177Lu- labeled MOv18 as compared to 131I- or 90Y-labeled MOv18 has the better therapeutic effect in eradication of alpha folate receptor-expressing tumor xenografts

  • Alberto Zacchetti

      Affiliations

    • Unit of Molecular Therapies, Department of Experimental Oncology and Laboratories, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy
    • ,
  • Angela Coliva

      Affiliations

    • Department of Imaging and Nuclear Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy
    • ,
  • Elena Luison

      Affiliations

    • Unit of Molecular Therapies, Department of Experimental Oncology and Laboratories, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy
    • ,
  • Ettore Seregni

      Affiliations

    • Department of Imaging and Nuclear Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy
    • ,
  • Emilio Bombardieri

      Affiliations

    • Department of Imaging and Nuclear Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy
    • ,
  • Augusto Giussani

      Affiliations

    • Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany
    • ,
  • Mariangela Figini

      Affiliations

    • Unit of Molecular Therapies, Department of Experimental Oncology and Laboratories, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy
    • M.F. and S.C. contributed equally to this work.
    • ,
  • Silvana Canevari

      Affiliations

    • Unit of Molecular Therapies, Department of Experimental Oncology and Laboratories, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +390223902567; fax: +390223903073.
    • M.F. and S.C. contributed equally to this work.

Received 31 March 2009; received in revised form 13 May 2009; accepted 15 May 2009. published online 30 July 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0969-8051(09)00129-2

doi:10.1016/j.nucmedbio.2009.05.004

Nuclear Medicine and Biology
Volume 36, Issue 7 , Pages 759-770, October 2009

Article Tools

* Image Usage & Resolution